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Background: True small vessels are supplying small myocardial territories
therefore functional significance of correspondent lesions is questionable.
Moreover, percutaneous coronary intervention (PCI) of not-functional small
vessel lesions might be associated with worse clinical outcome. The aim of
this study was to assess the clinical impact of Fractional Flow Reserve (FFR)
versus Angiography for guiding PCI in the treatment of small coronary vessel
lesions.
Methods and Results: From January 2004 to December 2008, all patients
treated with PCI for stable or unstable angina in a native small coronary vessel
(defined by a reference vessel diameter < 3mm) were enrolled. Patients were
divided into two groups according to type of strategy used: Angio vs. FFR-
guided PCI. A total of 717 patients were enrolled (495 Angio-guided PCI, 222
FFR-guided PCI). Clinical follow up was obtained in 97.5% (median follow-
up 3.3±1.3 years). The proportion of patients treated with drug-eluting stent
was similar in both groups. At five years, patients treated with FFR-guided
PCI showed significantly lower death or non-fatal myocardial infarction (MI)
(HR 0.41, 95%CI 0.23-0.75, p=0,004), target vessel revascularization (TVR)
(HR 0.52, 95%CI 0.32-0.83, p=0.006) and major adverse cardiac events
(MACE) (HR 0.46, 95%CI 0.31-0.68, p<0.001). No significant differences
were observed between the two groups as to death and myocardial infarction.
Costs of procedures were also reduced in FFR guided strategy (p<0.0001).
Conclusions: FFR-guided PCI is more effective than Angio-guided PCI in
reducing death or non-fatal MI, TVR and MACE and in patients with small
vessel disease.
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Long term prognosis impact of left ventricular systolic dysfunction in
coronary artery disease
Frédéric Bouisset [Orateur] (1), Vanina Bongard (2), Jean-Bernard Ruida-
vets (3), Dorota Taraszkiewicz (4), Michel Galinier (1), Didier Carrié (5),
Jean Ferrières (4), Meyer Elbaz (5)
(1) CHU Toulouse, Cardiologie A, Toulouse, France – (2) CHU Toulouse,
Inserm U1027, Epidémiologie, Toulouse, France – (3) CHU Toulouse,
Inserm U1027, Epidémiologie, Toulouse, France (4) CHU Rangueil, Car-
diologie B, Toulouse, France – (5) CHU Rangueil, Cardiologie B, Tou-
louse, France
Purpose: Our objective was to assess the long term prognosis impact of
LVEF in a contemporary large cohort of pts with established CAD.
Methods: Among 834 consecutive male pts hospitalized in 2001-2004 for
coronary artery disease, LVEF was assessed in 716 pts. LVEF >0.50 was con-
sidered as normal. Values between 0.50 and 0.35 were considered as low, and
LVEF 0.35 was considered as very low. The median follow-up was 7.17
years. Total mortality was predicted with a Cox proportional hazard model.
Results: Mean age (SD) was 60.2 (8.1), 144 pts (18.4%) were diabetic,
155 pts (19.8%) were smokers, mean blood pressure was 139 (20)/84 (11)
mmHg and median heart rate was 61 bpm [Interquatile range (IQR)] [57-70].
Mean Cockcroft-Gault creatinine clearance was 87 ml/min and 11 pts (1.4%)
had a severe chronic renal failure (lower than 30 ml/min). 88.5% were on anti-
platelet therapy, 75.2% on beta-blocker, 66% on statin therapy and 54.8% on
ACE inhibitors or ARB. The sample comprised 413 (57%) pts with normal
LVEF and 308 (43%) with systolic dysfunction (203 (65.9%) pts had a low
and 105 (34.1%) a very low LVEF). Among the 308 pts with systolic dysfunc-
tion, 78.2% were treated with beta blockers and 72.7% with ACE inhibitors or
ARB. The cumulative seven-year total mortality rate was 18.5% (8.6% in the
normal LEVF group whereas it was 23.6% and 47.6% in the low and the very
low LVEF groups, respectively, (p<0.001). After multivariate adjustment for
age, diabetes, tobacco consumption, heart rate, duration of CAD, ankle-bra-
chial index, history of chronic obstructive pulmonary disease or stroke, statin
therapy and coronary revascularization, hazard ratio for of all-cause death was
2.51 (95% CI [1.59; 3.95] p<0.001) for low LVEF and 4.27 ([2.67; 6.84]
p<0.001) for very low LVEF compared to pts with normal LVEF.
Conclusion: Left ventricular ejection fraction remains a strong and inde-
pendent long term predictor factor for all-cause death in CAD, even in a con-
temporary well treated cohort.
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Purpose: Early impairment of LV function using Brain Natriuretic Peptide
(BNP) level has been proposed to stratify asymptomatic Aortic Stenosis (AS)
with a poor outcome. Recent studies suggest that longitudinal global strain by
speckle tracking may be useful to detect early stages of LV dysfunction. The
purpose of the present study is to establish the relationship between longitu-
dinal global strain and NT-proBNP value in the setting of asymptomatic AS.
Methods: The study included 128 patients (74+/–12 years; 59% men,) with
moderate to severe AS (1.0±0.3 cm2) with preserved LVEF (>50%, 64+/–5%).
Longitudinal global strain by 2D speckle tracking was compared to the pres-
ence of symptoms and plasmatic NT-proBNP measurement.
Results: On the whole, NT-proBNP averaged 723±1097 pg/mL and was
higher in symptomatic patients (1203±1350 vs. 325±484 pg/mL, p<0.0001).
However, elevated NT-proBNP level (>500 pg/mL) was observed in 18%
asymptomatic patients (n=14/79). In asymptomatic patients, no difference was
found for LVEF (65±5 vs. 63±4%), peak aortic jet velocity (3.5±0.8 vs.
3.9±0.9 m.s-1) or aortic valve area (1.1±0.4 vs. 1.0±0.4 cm²) between patients
with and without elevated NTproBNP. Importantly, global longitudinal strain
was significantly impaired in asymptomatic patients with elevated NT-
proBNP (–17±4% vs. –19±3%, p<0.05) and did not differ from symptomatic
patients (–17±3%).
Conclusion: Impaired longitudinal global strain in asymptomatic aortic
stenosis is associated with an increase in NTproBNP level and may be used to
better identify falsely asymptomatic patients.
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Long-term impact of repeat percutaneous mitral commissurotomy on
the need for surgery in mitral stenosis. Insights from a series of
912 patients with a 20-year follow-up
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Purpose: Percutaneous mitral commissurotomy (PMC) can be repeated in
case of mitral restenosis. However, the impact of repeat PMC on the possi-
bility of deferring mitral surgery has not been specifically studied. We there-
fore analysed long-term follow-up (FU) after PMC, comparing survival
without re-intervention (surgery or repeat PMC) to survival without surgery
alone.
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